Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Inogen IncINGN · Entity 2083 | EVP, R&D & Chief Med. Officer | May 01, 2024 | May 03, 2024 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Inogen Inc
Report date May 01, 2024 · Filed May 03, 2024
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 32,049 |
Ending reported balance
After 2024-05-01 transaction · row 2
2 source rows · reconciled sequenceRow 1 · 2024-05-01 · Exercise / conversion · Acquired 32,638 · Balance 48,744 Row 2 · 2024-05-01 · Tax withholding · Disposed 16,695 · Balance 32,049 F1: The reported shares were withheld to cover the Reporting Person's tax withholding liability in connection with a portion of a time-based restricted stock award that vested on May 1, 2024. |
| Restricted Stock UnitSEC Table II · derivative / convertible security | Direct | 0 |
Reported balance
After 2024-05-01 transaction · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · 2024-05-01 · Exercise / conversion · Disposed 32,638 · Balance 0 F2: Each restricted stock unit represents a contingent right to receive one share of Inogen common stock. F3: Subject to the reporting person's continued service, one hundred percent (100%) of the restricted stock units shall vest on May 1, 2024 |
Filing footnotes · ownership attribution and instrument terms
F1: The reported shares were withheld to cover the Reporting Person's tax withholding liability in connection with a portion of a time-based restricted stock award that vested on May 1, 2024.
F2: Each restricted stock unit represents a contingent right to receive one share of Inogen common stock.
F3: Subject to the reporting person's continued service, one hundred percent (100%) of the restricted stock units shall vest on May 1, 2024
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| May 01, 2024 Filed May 3, 2024 22:14 UTC | Inogen Inc INGN · Entity 2083 | Exercise / conversionRestricted Stock Unit · Derivative | 32,638 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-24-053100 · ownership.xml · derivative · entry 3 Glezer Stanislav · CIK 0001866861 · EVP, R&D & Chief Med. Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 32,638 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Inogen common stock. F3 · derivative.exercise_date: Subject to the reporting person's continued service, one hundred percent (100%) of the restricted stock units shall vest on May 1, 2024 F3 · derivative.expiration_date: Subject to the reporting person's continued service, one hundred percent (100%) of the restricted stock units shall vest on May 1, 2024 Read SEC document |
| May 01, 2024 Filed May 3, 2024 22:14 UTC | Inogen Inc INGN · Entity 2083 | Tax withholdingCommon Stock | 16,695 | $7.05 | $117,699.75 |
DisclosureSEC source: 0000950170-24-053100 · ownership.xml · nonDerivative · entry 2 Glezer Stanislav · CIK 0001866861 · EVP, R&D & Chief Med. Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 32,049 F1 · shares: The reported shares were withheld to cover the Reporting Person's tax withholding liability in connection with a portion of a time-based restricted stock award that vested on May 1, 2024. Read SEC document |
| May 01, 2024 Filed May 3, 2024 22:14 UTC | Inogen Inc INGN · Entity 2083 | Exercise / conversionCommon Stock | 32,638 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-24-053100 · ownership.xml · nonDerivative · entry 1 Glezer Stanislav · CIK 0001866861 · EVP, R&D & Chief Med. Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 48,744 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 01, 2024 Filed Mar 6, 2024 00:08 UTC | Inogen Inc INGN · Entity 2083 | GrantRestricted Stock Unit · Derivative | 43,993 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-24-026541 · ownership.xml · derivative · entry 6 Glezer Stanislav · CIK 0001866861 · EVP, R&D & Chief Med. Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 43,993 Underlying: Common Stock · 43,993 shares Expires not disclosed F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Inogen common stock. F6 · derivative.exercise_date: Subject to the reporting person's continued service, 1/3rd of the restricted stock units shall vest on March 1, 2025, and 1/3rd of the restricted stock units shall vest every year thereafter on the same day of the year as the Vesting Commencement Date. F6 · derivative.expiration_date: Subject to the reporting person's continued service, 1/3rd of the restricted stock units shall vest on March 1, 2025, and 1/3rd of the restricted stock units shall vest every year thereafter on the same day of the year as the Vesting Commencement Date. Read SEC document |
| March 01, 2024 Filed Mar 6, 2024 00:08 UTC | Inogen Inc INGN · Entity 2083 | Exercise / conversionRestricted Stock Unit · Derivative | 9,360 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-24-026541 · ownership.xml · derivative · entry 5 Glezer Stanislav · CIK 0001866861 · EVP, R&D & Chief Med. Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 18,719 Underlying: Common Stock · 9,360 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Inogen common stock. F5 · derivative.exercise_date: Subject to the reporting person's continued service, 1/3rd of the restricted stock units shall vest on March 1, 2024, and 1/3rd of the restricted stock units shall vest every year thereafter on the same day of the year as the Vesting Commencement Date. F5 · derivative.expiration_date: Subject to the reporting person's continued service, 1/3rd of the restricted stock units shall vest on March 1, 2024, and 1/3rd of the restricted stock units shall vest every year thereafter on the same day of the year as the Vesting Commencement Date. Read SEC document |
| March 01, 2024 Filed Mar 6, 2024 00:08 UTC | Inogen Inc INGN · Entity 2083 | Exercise / conversionRestricted Stock Unit · Derivative | 3,786 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-24-026541 · ownership.xml · derivative · entry 4 Glezer Stanislav · CIK 0001866861 · EVP, R&D & Chief Med. Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,787 Underlying: Common Stock · 3,786 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Inogen common stock. F4 · derivative.exercise_date: Subject to the reporting person's continued service, 1/3rd of the restricted stock units shall vest on March 1, 2023, and 1/3rd of the restricted stock units shall vest every year thereafter on the same day of the year as the Vesting Commencement Date. F4 · derivative.expiration_date: Subject to the reporting person's continued service, 1/3rd of the restricted stock units shall vest on March 1, 2023, and 1/3rd of the restricted stock units shall vest every year thereafter on the same day of the year as the Vesting Commencement Date. Read SEC document |
| March 01, 2024 Filed Mar 6, 2024 00:08 UTC | Inogen Inc INGN · Entity 2083 | Exercise / conversionRestricted Stock Unit · Derivative | 768 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-24-026541 · ownership.xml · derivative · entry 3 Glezer Stanislav · CIK 0001866861 · EVP, R&D & Chief Med. Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,612 Underlying: Common Stock · 768 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Inogen common stock. F3 · derivative.exercise_date: Subject to the reporting person's continued service, 25% of the restricted stock units shall vest on September 1, 2022, and 1/16th of the restricted stock units shall vest every three months thereafter on the 1st day of the month. F3 · derivative.expiration_date: Subject to the reporting person's continued service, 25% of the restricted stock units shall vest on September 1, 2022, and 1/16th of the restricted stock units shall vest every three months thereafter on the 1st day of the month. Read SEC document |
| March 01, 2024 Filed Mar 6, 2024 00:08 UTC | Inogen Inc INGN · Entity 2083 | Tax withholdingCommon Stock | 7,623 | $7.03 | $53,551.58 |
DisclosureSEC source: 0000950170-24-026541 · ownership.xml · nonDerivative · entry 2 Glezer Stanislav · CIK 0001866861 · EVP, R&D & Chief Med. Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 16,106 F1 · shares: The reported shares were withheld to cover the Reporting Person's tax withholding liability in connection with a portion of a time-based restricted stock award that vested on March 1, 2024. Read SEC document |
| March 01, 2024 Filed Mar 6, 2024 00:08 UTC | Inogen Inc INGN · Entity 2083 | Exercise / conversionCommon Stock | 13,914 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-24-026541 · ownership.xml · nonDerivative · entry 1 Glezer Stanislav · CIK 0001866861 · EVP, R&D & Chief Med. Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 23,729 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 01, 2023 Filed Dec 4, 2023 23:29 UTC | Inogen Inc INGN · Entity 2083 | Exercise / conversionRestricted Stock Unit · Derivative | 3,786 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-057302 · doc4.xml · derivative · entry 4 Glezer Stanislav · CIK 0001866861 · EVP, Chief Technology Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,787 Underlying: Common Stock · 3,786 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Inogen common stock. F4 · derivative.exercise_date: Subject to the reporting person's continued service, 1/3rd of the restricted stock units shall vest on December 1, 2022, and 1/3rd of the restricted stock units shall vest every year thereafter on the same day of the year as the vesting commencement date. F4 · derivative.expiration_date: Subject to the reporting person's continued service, 1/3rd of the restricted stock units shall vest on December 1, 2022, and 1/3rd of the restricted stock units shall vest every year thereafter on the same day of the year as the vesting commencement date. Read SEC document |
| December 01, 2023 Filed Dec 4, 2023 23:29 UTC | Inogen Inc INGN · Entity 2083 | Exercise / conversionRestricted Stock Unit · Derivative | 769 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-057302 · doc4.xml · derivative · entry 3 Glezer Stanislav · CIK 0001866861 · EVP, Chief Technology Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,380 Underlying: Common Stock · 769 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Inogen common stock. F3 · derivative.exercise_date: Subject to the reporting person's continued service, 25% of the restricted stock units shall vest on September 1, 2022, and 1/16th of the restricted stock units shall vest every three months thereafter on the 1st day of the month. F3 · derivative.expiration_date: Subject to the reporting person's continued service, 25% of the restricted stock units shall vest on September 1, 2022, and 1/16th of the restricted stock units shall vest every three months thereafter on the 1st day of the month. Read SEC document |
| December 01, 2023 Filed Dec 4, 2023 23:29 UTC | Inogen Inc INGN · Entity 2083 | Tax withholdingCommon Stock | 2,331 | $5.72 | $13,333.32 |
DisclosureSEC source: 0001209191-23-057302 · doc4.xml · nonDerivative · entry 2 Glezer Stanislav · CIK 0001866861 · EVP, Chief Technology Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 9,815 F1 · shares: The reported shares were withheld to cover the Reporting Person's tax withholding liability in connection with a portion of a time-based restricted stock award that vested on December 1, 2023. Read SEC document |
| December 01, 2023 Filed Dec 4, 2023 23:29 UTC | Inogen Inc INGN · Entity 2083 | Exercise / conversionCommon Stock | 4,555 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-057302 · doc4.xml · nonDerivative · entry 1 Glezer Stanislav · CIK 0001866861 · EVP, Chief Technology Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 12,146 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 01, 2023 Filed Sep 5, 2023 22:22 UTC | Inogen Inc INGN · Entity 2083 | Exercise / conversionRestricted Stock Unit · Derivative | 769 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-048238 · doc4.xml · derivative · entry 3 Glezer Stanislav · CIK 0001866861 · EVP, Chief Technology Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,149 Underlying: Common Stock · 769 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Inogen common stock. F3 · derivative.exercise_date: Subject to the reporting person's continued service, 25% of the restricted stock units shall vest on September 1, 2022, and 1/16th of the restricted stock units shall vest every three months thereafter on the 1st day of the month. F3 · derivative.expiration_date: Subject to the reporting person's continued service, 25% of the restricted stock units shall vest on September 1, 2022, and 1/16th of the restricted stock units shall vest every three months thereafter on the 1st day of the month. Read SEC document |
| September 01, 2023 Filed Sep 5, 2023 22:22 UTC | Inogen Inc INGN · Entity 2083 | Tax withholdingCommon Stock | 394 | $6.18 | $2,434.92 |
DisclosureSEC source: 0001209191-23-048238 · doc4.xml · nonDerivative · entry 2 Glezer Stanislav · CIK 0001866861 · EVP, Chief Technology Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,591 F1 · shares: The reported shares were withheld to cover the Reporting Person's tax withholding liability in connection with a portion of a time-based restricted stock award that vested on September 1, 2023. Read SEC document |
| September 01, 2023 Filed Sep 5, 2023 22:22 UTC | Inogen Inc INGN · Entity 2083 | Exercise / conversionCommon Stock | 769 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-048238 · doc4.xml · nonDerivative · entry 1 Glezer Stanislav · CIK 0001866861 · EVP, Chief Technology Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,985 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 01, 2023 Filed Jun 5, 2023 20:44 UTC | Inogen Inc INGN · Entity 2083 | Exercise / conversionRestricted Stock Unit · Derivative | 768 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-034376 · doc4.xml · derivative · entry 3 Glezer Stanislav · CIK 0001866861 · EVP, Chief Technology Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,918 Underlying: Common Stock · 768 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Inogen common stock. F3 · derivative.exercise_date: Subject to the reporting person's continued service, 25% of the restricted stock units shall vest on September 1, 2022, and 1/16th of the restricted stock units shall vest every three months thereafter on the 1st day of the month. F3 · derivative.expiration_date: Subject to the reporting person's continued service, 25% of the restricted stock units shall vest on September 1, 2022, and 1/16th of the restricted stock units shall vest every three months thereafter on the 1st day of the month. Read SEC document |
| June 01, 2023 Filed Jun 5, 2023 20:44 UTC | Inogen Inc INGN · Entity 2083 | Tax withholdingCommon Stock | 393 | $10.37 | $4,075.41 |
DisclosureSEC source: 0001209191-23-034376 · doc4.xml · nonDerivative · entry 2 Glezer Stanislav · CIK 0001866861 · EVP, Chief Technology Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,216 F1 · shares: The reported shares were withheld to cover the Reporting Person's tax withholding liability in connection with a portion of a time-based restricted stock award that vested on June 1, 2023. Read SEC document |
| June 01, 2023 Filed Jun 5, 2023 20:44 UTC | Inogen Inc INGN · Entity 2083 | Exercise / conversionCommon Stock | 768 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-034376 · doc4.xml · nonDerivative · entry 1 Glezer Stanislav · CIK 0001866861 · EVP, Chief Technology Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,609 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 01, 2023 Filed Mar 3, 2023 01:37 UTC | Inogen Inc INGN · Entity 2083 | Exercise / conversionRestricted Stock Unit · Derivative | 3,787 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-015041 · doc4.xml · derivative · entry 6 Glezer Stanislav · CIK 0001866861 · EVP, Chief Technology Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,573 Underlying: Common Stock · 3,787 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Inogen common stock. F6 · derivative.exercise_date: Subject to the reporting person's continued service, 1/3rd of the restricted stock units shall vest on March 1, 2023, and 1/3rd of the restricted stock units shall vest every year thereafter on the same day of the year as the vesting commencement date. F6 · derivative.expiration_date: Subject to the reporting person's continued service, 1/3rd of the restricted stock units shall vest on March 1, 2023, and 1/3rd of the restricted stock units shall vest every year thereafter on the same day of the year as the vesting commencement date. Read SEC document |
| March 01, 2023 Filed Mar 3, 2023 01:37 UTC | Inogen Inc INGN · Entity 2083 | Exercise / conversionRestricted Stock Unit · Derivative | 769 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-015041 · doc4.xml · derivative · entry 5 Glezer Stanislav · CIK 0001866861 · EVP, Chief Technology Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,686 Underlying: Common Stock · 769 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Inogen common stock. F5 · derivative.exercise_date: Subject to the reporting person's continued service, 25% of the restricted stock units shall vest on September 1, 2022, and 1/16th of the restricted stock units shall vest every three months thereafter on the 1st day of the month. F5 · derivative.expiration_date: Subject to the reporting person's continued service, 25% of the restricted stock units shall vest on September 1, 2022, and 1/16th of the restricted stock units shall vest every three months thereafter on the 1st day of the month. Read SEC document |
| March 01, 2023 Filed Mar 3, 2023 01:37 UTC | Inogen Inc INGN · Entity 2083 | Tax withholdingCommon Stock | 2,568 | $15.56 | $39,958.08 |
DisclosureSEC source: 0001209191-23-015041 · doc4.xml · nonDerivative · entry 4 Glezer Stanislav · CIK 0001866861 · EVP, Chief Technology Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,841 F3 · shares: The reported shares were withheld to cover the Reporting Person's tax withholding liability in connection with a portion of a time-based restricted stock award that vested on March 1, 2023. Read SEC document |
| March 01, 2023 Filed Mar 3, 2023 01:37 UTC | Inogen Inc INGN · Entity 2083 | Exercise / conversionCommon Stock | 4,556 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-015041 · doc4.xml · nonDerivative · entry 3 Glezer Stanislav · CIK 0001866861 · EVP, Chief Technology Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,409 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 01, 2023 Filed Mar 3, 2023 01:37 UTC | Inogen Inc INGN · Entity 2083 | Tax withholdingCommon Stock | 1,142 | $15.56 | $17,769.52 |
DisclosureSEC source: 0001209191-23-015041 · doc4.xml · nonDerivative · entry 2 Glezer Stanislav · CIK 0001866861 · EVP, Chief Technology Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,853 F2 · shares: The reported shares were withheld to cover the Reporting Person's tax withholding liability in connection with the 2022 performance-based restricted award granted on March 1, 2022 and vested on March 1, 2023. Read SEC document |
| March 01, 2023 Filed Mar 3, 2023 01:37 UTC | Inogen Inc INGN · Entity 2083 | GrantCommon Stock | 2,272 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-015041 · doc4.xml · nonDerivative · entry 1 Glezer Stanislav · CIK 0001866861 · EVP, Chief Technology Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,995 F1 · shares: The reported securities represent shares earned and vested on March 1, 2023 based on achievement of the financial performance conditions for the 2022 fiscal year that were approved as part of the 2022 performance-based restricted stock award granted on March 1, 2022. Read SEC document |
| February 28, 2023 Filed Mar 3, 2023 01:37 UTC | Inogen Inc INGN · Entity 2083 | GrantRestricted Stock Unit · Derivative | 28,079 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-015041 · doc4.xml · derivative · entry 7 Glezer Stanislav · CIK 0001866861 · EVP, Chief Technology Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,079 Underlying: Common Stock · 28,079 shares Expires not disclosed F4 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Inogen common stock. F7 · derivative.exercise_date: Subject to the reporting person's continued service, 1/3rd of the restricted stock units shall vest on March 1, 2024, and 1/3rd of the restricted stock units shall vest every year thereafter on the same day of the year as the vesting commencement date. F7 · derivative.expiration_date: Subject to the reporting person's continued service, 1/3rd of the restricted stock units shall vest on March 1, 2024, and 1/3rd of the restricted stock units shall vest every year thereafter on the same day of the year as the vesting commencement date. Read SEC document |
| December 01, 2022 Filed Dec 6, 2022 00:27 UTC | Inogen Inc INGN · Entity 2083 | Exercise / conversionRestricted Stock Unit · Derivative | 3,787 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-059867 · doc4.xml · derivative · entry 4 Glezer Stanislav · CIK 0001866861 · EVP, Chief Technology Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,573 Underlying: Common Stock · 3,787 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Inogen common stock. F4 · derivative.exercise_date: Subject to the reporting person's continued service, 1/3rd of the restricted stock units shall vest on December 1, 2022, and 1/3rd of the restricted stock units shall vest every year thereafter on the same day of the year as the vesting commencement date. F4 · derivative.expiration_date: Subject to the reporting person's continued service, 1/3rd of the restricted stock units shall vest on December 1, 2022, and 1/3rd of the restricted stock units shall vest every year thereafter on the same day of the year as the vesting commencement date. Read SEC document |
| December 01, 2022 Filed Dec 6, 2022 00:27 UTC | Inogen Inc INGN · Entity 2083 | Exercise / conversionRestricted Stock Unit · Derivative | 768 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-059867 · doc4.xml · derivative · entry 3 Glezer Stanislav · CIK 0001866861 · EVP, Chief Technology Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,455 Underlying: Common Stock · 768 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Inogen common stock. F3 · derivative.exercise_date: Subject to the reporting person's continued service, 25% of the restricted stock units shall vest on September 1, 2022, and 1/16th of the restricted stock units shall vest every three months thereafter on the 1st day of the month. F3 · derivative.expiration_date: Subject to the reporting person's continued service, 25% of the restricted stock units shall vest on September 1, 2022, and 1/16th of the restricted stock units shall vest every three months thereafter on the 1st day of the month. Read SEC document |
| December 01, 2022 Filed Dec 6, 2022 00:27 UTC | Inogen Inc INGN · Entity 2083 | Tax withholdingCommon Stock | 2,331 | $22.89 | $53,356.59 |
DisclosureSEC source: 0001209191-22-059867 · doc4.xml · nonDerivative · entry 2 Glezer Stanislav · CIK 0001866861 · EVP, Chief Technology Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,723 F1 · shares: The reported shares were withheld to cover the Reporting Person's tax withholding liability in connection with a portion of a time-based restricted stock award that vested on December 1, 2022. Read SEC document |
| December 01, 2022 Filed Dec 6, 2022 00:27 UTC | Inogen Inc INGN · Entity 2083 | Exercise / conversionCommon Stock | 4,555 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-059867 · doc4.xml · nonDerivative · entry 1 Glezer Stanislav · CIK 0001866861 · EVP, Chief Technology Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,054 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 01, 2022 Filed Sep 7, 2022 01:27 UTC | Inogen Inc INGN · Entity 2083 | Exercise / conversionRestricted Stock Unit · Derivative | 3,075 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-048941 · doc4.xml · derivative · entry 3 Glezer Stanislav · CIK 0001866861 · EVP, Chief Technology Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,223 Underlying: Common Stock · 3,075 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Inogen common stock. F3 · derivative.exercise_date: Subject to the reporting person's continued service, 25% of the restricted stock units shall vest on September 1, 2022, and 1/16th of the restricted stock units shall vest every three months thereafter on the 1st day of the month. F3 · derivative.expiration_date: Subject to the reporting person's continued service, 25% of the restricted stock units shall vest on September 1, 2022, and 1/16th of the restricted stock units shall vest every three months thereafter on the 1st day of the month. Read SEC document |
| September 01, 2022 Filed Sep 7, 2022 01:27 UTC | Inogen Inc INGN · Entity 2083 | SaleCommon Stock | 1,576 | $28.16 | $44,380.16 |
DisclosureSEC source: 0001209191-22-048941 · doc4.xml · nonDerivative · entry 2 Glezer Stanislav · CIK 0001866861 · EVP, Chief Technology Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,499 F1 · shares: The reported shares were sold to cover the Reporting Person's tax withholding liability in connection with a portion of a time-based restricted stock award that vested on September 1, 2022. Read SEC document |
| September 01, 2022 Filed Sep 7, 2022 01:27 UTC | Inogen Inc INGN · Entity 2083 | Exercise / conversionCommon Stock | 3,075 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-048941 · doc4.xml · nonDerivative · entry 1 Glezer Stanislav · CIK 0001866861 · EVP, Chief Technology Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,075 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 10, 2022 Filed May 12, 2022 22:24 UTC | Inogen Inc INGN · Entity 2083 | GrantRestricted Stock Unit · Derivative | 32,638 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-028624 · doc4.xml · derivative · entry 1 Glezer Stanislav · CIK 0001866861 · EVP, Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 32,638 Underlying: Common Stock · 32,638 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Inogen common stock. F2 · derivative.exercise_date: Subject to the reporting person's continued service, one hundred percent (100%) of the restricted stock units shall vest on May 1, 2024. F2 · derivative.expiration_date: Subject to the reporting person's continued service, one hundred percent (100%) of the restricted stock units shall vest on May 1, 2024. Read SEC document |
| March 01, 2022 Filed Mar 4, 2022 01:54 UTC | Inogen Inc INGN · Entity 2083 | GrantRestricted Stock Unit · Derivative | 11,360 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-016017 · doc4.xml · derivative · entry 2 Glezer Stanislav · CIK 0001866861 · EVP, Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,360 Underlying: Common Stock · 11,360 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Inogen common stock. F3 · derivative.exercise_date: Subject to the reporting person's continued service, 1/3rd of the restricted stock units shall vest on December 1, 2022, and 1/3rd of the restricted stock units shall vest every year thereafter on the same day of the year as the vesting commencement date. F3 · derivative.expiration_date: Subject to the reporting person's continued service, 1/3rd of the restricted stock units shall vest on December 1, 2022, and 1/3rd of the restricted stock units shall vest every year thereafter on the same day of the year as the vesting commencement date. Read SEC document |
| March 01, 2022 Filed Mar 4, 2022 01:54 UTC | Inogen Inc INGN · Entity 2083 | GrantRestricted Stock Unit · Derivative | 11,360 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-016017 · doc4.xml · derivative · entry 1 Glezer Stanislav · CIK 0001866861 · EVP, Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,360 Underlying: Common Stock · 11,360 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Inogen common stock. F2 · derivative.exercise_date: Subject to the reporting person's continued service, 1/3rd of the restricted stock units shall vest on March 1, 2023, and 1/3rd of the restricted stock units shall vest every year thereafter on the same day of the year as the vesting commencement date. F2 · derivative.expiration_date: Subject to the reporting person's continued service, 1/3rd of the restricted stock units shall vest on March 1, 2023, and 1/3rd of the restricted stock units shall vest every year thereafter on the same day of the year as the vesting commencement date. Read SEC document |
| August 09, 2021 Filed Aug 11, 2021 13:21 UTC | Inogen Inc INGN · Entity 2083 | GrantRestricted Stock Unit · Derivative | 12,298 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-050762 · doc4.xml · derivative · entry 1 Glezer Stanislav · CIK 0001866861 · EVP, Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,298 Underlying: Common Stock · 12,298 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Inogen common stock. F2 · derivative.exercise_date: Subject to the reporting person's continued service, 25% of the restricted stock units shall vest on September 1, 2022, and 1/16th of the restricted stock units shall vest every three months thereafter on the 1st day of the month. F2 · derivative.expiration_date: Subject to the reporting person's continued service, 25% of the restricted stock units shall vest on September 1, 2022, and 1/16th of the restricted stock units shall vest every three months thereafter on the 1st day of the month. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.